The Overactive Bladder
Evaluation and Management
1st Edition
Published on 10. July 2007
448 pages
978-1-135-40524-3 (ISBN)
Description
Overactive bladder (OAB) affects millions of men and women daily. Given the symptoms of sleep loss, depression, and a lower quality of life than even those with diabetes mellitus, effective and beneficial treatment is a must for these people. Drs Kreder and Dmochowski, both recognized experts on voiding dysfunction and urodynamics, have a
Reviews / Votes
"This book is a valuable update on the overactive bladder and will be a very useful guide for daily practice for urologists, urogynaecologists, urologic and pelvis surgeons, both qualified and in training." Jane Meijlink, ICS News"With 51 contributors from five different countries, this book provides extensive and comprehensive information about the overactive bladder (OAB). [...] this book provides an excellent insight into OAB. It deals with why it occurs, assessment, diagnosis and the numerous management options. It is a must read for all urologists, from trainee to consultant." Bill Papadopoulos, Urology News, Vol 12 No 3, March 2008
More details
Edition
1. Auflage
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
Professional and scholarly
Product notice
Reflowable
ISBN-13
978-1-135-40524-3 (9781135405243)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Book
07/2007
1st Edition
CRC Press
€319.93
Shipment within 3-4 weeks
Content
Section 1, INTRODUCTION 1. Nomenclature. 2. The Neurophysiology of Lower Urinary Tract Function. 3. The Diagnosis of Overactive Bladder. 4. Measuring OAB Symptoms. 5. Nocturia. 6. Urodynamics. 7. Urgency-Frequency Syndome and Pelvic Pain, and Interstitial Cystitis. 8. Pelvic Floor Muscle Exercises and Behavioral Therapy. Section 2, PHARMACOLOGY 9. Basic Pharmacology. 10. Drug Delivery and Intravesical Instillation. 11. Pioneering Agents: Immediate-Release. 12. Tricyclic Antidepressants. 13. Propiverine Hydrochloride. 14. Extended Release Oral Oxybutynin. 15. Tolterodine. 16. Trospium Chloride. 17. Darifenacin. 18. Solifenacin Succinate. 19. Transdermal Oxybutynin (Oxytrol). 20. Strategies for Data Comparison for Drugs. 21. Pharmacotherapy of OAB in Bladder Outlet Obstruction. 22. Botulinum Toxin (Botox). 23. Acupuncture. 24. Fesoterodine. Section 3, NEUROMODULATION 25. Neuromodulation: Mechanisms of Action. 26. Sacral Nerve Stimulation. 27. The Bion Microstimulator. 28. The Miniaturo-I Device. Section 4, SURGICAL THERAPY 29. Transvaginal Denervation. 30. Autoaugmentation. 31. Augmentation Cystoplasty. Section 5, SPECIAL CONSIDERATIONS 32. Children. 33. Geriatric Population 34. Late Breaking Information
